Thursday, May 12, 2016

BRIEF-Catabasis Pharmaceuticals reports Q1 loss per share $0.61

* Q1 earnings per share view $-0.64 -- Thomson Reuters

I/B/E/S

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +1-646-223-8780)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)